Salut Lausanne 🇨🇭, Graph’s Senior Research Scientist Rin Okumura will be at the 2nd Symposium on the Immunobiology of Pattern Recognition Receptors hosted by @unil.bsky.social from 1 - 2 October! We’re excited to explore and discuss the latest discoveries in innate immune research. 💪 🧬

How can we best drive ideation, funding, and operation of academic-spin outs and academically linked ventures that span interdisciplinary fields, while keeping the end goal of patient success in mind? 💡⚙️

Hey Vienna 🇦🇹, Graph will be at the @aithyra.bsky.social Symposium “AI for Life Science” from 8 - 10 September! We’re looking forward to attending many of the talks by an outstanding line up of speakers. Let us know if you’re around and let’s talk! 💬 ☕

Meet the team behind Graph and say hello to Christophe Boudesco, VP Immunology! 👋 🥼 Better algorithms and better biological validations go hand in hand. The expertise that Christophe brings will help the team at Graph reduce biological uncertainty early and systematically. ➕✖️

Servus Vienna! 🇦🇹 Christophe Boudesco, Graph’s VP Immunology, will be at the 19th International Congress of Immunology (IUIS 2025) in Vienna from 17 - 22 August. Let us know if you’ll be around and let’s talk translational immunology! 🔬🧬

With its strong academic network & public-private partnerships, Vienna takes a leading role in shaping the bio x AI ecosystem. We're excited to be a part of this and to help it grow! 🌿 Great read about the history & scope of biotech in the 🇦🇹 capital. Check it out! ➡️ www.labiotech.eu/in-depth/vie...

After a year of building again in the techbio space, the Graph co-founders have written a deep dive on why precision medicine requires precision data. ➡️ Check it out: graphtx.substack.com/p/precision-...

Meet the team behind Graph and say hello to @kdris.bsky.social, Head of AI! 👋 🦜 Target discovery in immunology is a complex process. Bringing together individuals who have deep knowledge in adjacent domains helps us approach the challenges from multiple angles. ➕✖️

Happy 1st bday, Graph! 🎈 We've gone from an idea to a team of 11 (recruiting #12!), building lab-in-the-loop infrastructure, fueled by $5M in funding & academic collabs. We had a great time celebrating our journey with the team & reflecting on our mission to rebalance dysregulated immune systems! ➕✖️

We're hiring! 📢 Our team is looking for a Quantitative Systems Biologist driving research at the interface of computational and lab biology. 🧪🥼🔍 Want to know more? Reach out to us and apply via the link below! ⬇️ www.linkedin.com/jobs/view/42...

Meet the team behind Graph and say hello to Daniel Thomas, MLOps & data engineer! 👋 💬 We’re excited to have you along for the journey! Here’s to discovering better therapeutics for immune-mediated diseases by bridging the gap between biology and machine learning. ➕✖️

💡How are we using disease perturbational modeling & AI to transform the treatment of immunological diseases? In the AWS Health podcast, Graph's co-founder & CEO @gregvladimer.bsky.social talks science, tech, & where the future is headed in target discovery. 🎧 Check out the podcast! ➡️ bit.ly/43b5LAw

Excited to be joining the panel discussion later today! ✨ Mark your calendars! 📅 The @WiMLWorkshop Social returns to @iclrconf! 🗓️ Friday, April 25th, 2025 ⏰ 12:30 PM - 2:00 PM 📍 Hall 1 Apex, Singapore Expo iclr.cc/virtual/2025... lu.ma/ftdnjnf9 #ICLR2025

Graph receives the Deep Tech Life Science Seed Financing grant from the Austria Wirthschafts Service (AWS) worth EUR 1.1M! This accelerates our AI-driven platform technology and lab-in-the-loop approach to discover better data, targets, validation & biomarkers for immune & inflammatory diseases. 🎯🧬

Hey Singapore, @kdris.bsky.social will be at ICLR 2025 from 24 - 28 April! We’re looking forward to hearing about the latest discoveries in biology, AI, and deep learning. Let us know if you’ll be around! 🇸🇬

Just came back from the IRB conference in Barcelona on BioxAI. Still amazed by the speed at which (Gen)AI is already transforming comp bio research. Had fun catching up with familiar faces and made new connections. Huge thanks to the organisers for putting up cool program with top-notch line ups!

📣 Congratulations to Graph scientific co-founder Berend Snijder on his new appointment as Faculty Professor and Research Group Leader at the Botnar Institute of Immune Engineering (BIIE)! Here’s to even more groundbreaking work and discoveries. 🥂💥 ➡️ Read more: immune.engineering/news/dr-bere...

¡Hola! 🇪🇸 We’re looking forward to seeing everyone at the @irbbarcelona.org for the AI in Drug Discovery and Biomedicine conference. If you’re around, reach out to @izepb.bsky.social and let's meet up! 👋

We're back on the circuit at BIO-Europe Spring in Milan! ☕ 🇮🇹 @gregvladimer.bsky.social kicked off the 2nd day with a presentation about Graph, specifically how we combine complex immunological models, multi-modal data, and AI to tackle the drug discovery complexities of immune-mediated diseases. 👏

Graph has been awarded an Austrian Life Sciences grant worth EUR 1.1M from the FFG (Austrian Research Promotion Agency)! This funding helps us continue to develop our lab-in-the-loop AI-driven approach to discover better therapeutics for immune-mediated diseases. 🔬🚀

Anyone around Milan 🇮🇹 from 17 - 19 March? We’ll be there! Come and say Ciao! to our CEO & cofounder @gregvladimer.bsky.social and connect with us at BIO-Europe Spring!

Thanks to @izepb.bsky.social for organizing the first Vienna 🇦🇹 @techbio.bsky.social meetup! What a great way to bring everyone together and to build connections in unexpected places. Dankeschön and until next time! 👏

🔬🧬 AI x bio arrives in Paris! Come say Salut! to Graph's @kdris.bsky.social & the techbio community for the @techbio.bsky.social x @bitsinbio.bsky.social meetup, co-hosted with ORAKL Oncology, Speedinvest, & BioLabs. 25 Feb @ 18:30. Join the waitlist: lu.ma/3vavwseg

Graph Therapeutics announces the closing of a $3.1M pre-seed round aimed at bringing the precision medicine paradigm to inflammation and immunology (I&I). 🚀🔬🧬 Looking forward to great things to come! Read more ➡️ graphtx.com/news#graph-p...